Jubilant Ingrevia Debt & Borrowing: ₹100 Cr
Jubilant Ingrevia has issued Commercial Papers worth Rs. 100 Crore. This issuance, with a 90-day tenure, falls within the previously approved Rs. 600 Crore outstanding limit.
- Value
- ₹100.0 Cr
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
15 announcements with these filters
Jubilant Ingrevia has issued Commercial Papers worth Rs. 100 Crore. This issuance, with a 90-day tenure, falls within the previously approved Rs. 600 Crore outstanding limit.
Jubilant Ingrevia Employees Welfare Trust sold 8,807 shares worth Rs.0.56 Crore. The sale was executed to facilitate the exercise of ESOP options.
Jubilant Ingrevia Employees Welfare Trust sold 2,587 equity shares worth Rs. 0.17 Crore on September 11, 2026.
Jubilant Ingrevia Employees Welfare Trust sold 5,622 equity shares for Rs. 0.38 Crore. The transfer was executed pursuant to the exercise of ESOPs.
Jubilant Ingrevia Ltd held its 7th AGM on August 26, 2026. All proposed resolutions, including dividend declaration and director appointments, were duly passed by members.
Jubilant Ingrevia Employees Welfare Trust sold 2,627 shares valued at ₹0.19 Crore, as disclosed in a regulatory filing under PIT Regulations.
Jubilant Ingrevia Ltd will acquire a 40% strategic stake in Zettaone Technologies for ₹189.2 Crore. This investment strengthens the company's presence in the electronics design and manufacturing space.
Jubilant Ingrevia informed shareholders with unregistered emails about accessing the Annual Report and AGM notice for FY 2025-26 via the company website.
Jubilant Ingrevia has submitted its Business Responsibility and Sustainability Report (BRSR) for the Financial Year 2025-26 as per SEBI regulations.
Jubilant Ingrevia Ltd has scheduled its 7th Annual General Meeting for August 26, 2026. The meeting agenda includes dividend declaration and re-appointment of directors.
Jubilant Ingrevia reported a strong Q1 FY27 with revenue at a 15-quarter high of INR 1,300 Cr (up 25% YoY). Strategy focuses on the 'Pinnacle' journey, expanding CDMO and Specialty Chemical pipelines.
Jubilant Ingrevia Ltd reported revenue from operations of ₹1,300 Cr (+25.2% YoY) and net profit of ₹106 Cr (+41.3% YoY) for Q1 FY27.
Jubilant Ingrevia Ltd reported revenue from operations of ₹1,300 Cr (+25.3% YoY) and net profit of ₹105.8 Cr (+40.9% YoY) for Q1 FY27.
Jubilant Ingrevia has granted 42,298 stock options to eligible employees. These include both Restricted Stock Units and Performance Linked Stock Units.
Jubilant Ingrevia scheduled a board meeting for July 22, 2026. The board will consider standalone and consolidated financial results for the quarter ended June 30, 2026.